Point72 Asset Management’s Gilead Sciences GILD Stock Holding History

Point72 Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.73M	Sell	12,400 -4,400	-26%	-$616K	﹤0.01%	2413
2025 Q4	$2.06M	Buy	+16,800	New	+$2.04M	﹤0.01%	2452
2025 Q2	–	Sell	-75,000	Closed	-$8.4M	–	2353
2025 Q1	$8.4M	Buy	+75,000	New	+$7.74M	0.02%	745
2022 Q1	–	Sell	-500,000	Closed	-$36.3M	–	1245
2021 Q4	$36.3M	Buy	+500,000	New	+$34.4M	0.15%	192
2017 Q3	–	Sell	-500,000	Closed	-$35.4M	–	937
2017 Q2	$35.4M	Buy	+500,000	New	+$33.3M	0.2%	140

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Point72 Asset Management's GILD Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 8,808 shares worth $1.23M. The stake represents ﹤0.01% of the portfolio and ranks #2621 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in GILD as recently as Q2 2025.

Point72 Asset Management first reported a position in GILD in Q4 2014 and has held it in 27 quarters since. The position peaked at $232M in Q1 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Point72 Asset Management held 8,808 shares of Gilead Sciences worth $1.23M as of Q1 2026.
Gilead Sciences was a new Point72 Asset Management position in Q1 2026.
Gilead Sciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2621 holding.
Point72 Asset Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 27 quarters since.
Point72 Asset Management's Gilead Sciences position peaked at $232M in Q1 2018.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.